[Cancer diagnosis during pregnancy: importance of a national and European registration].

Abstract

Cancer during pregnancy is relatively rare, but its incidence has been increasing over recent years. A European study has been launched in 2005 by F. Amant (KUL) to register all pregnant patients with a cancer diagnosis with or without treatment during pregnancy (surgery, chemotherapy and/or radiotherapy). All infants exposed to chemotherapy and/or radiotherapy are also followed up by pediatricians, neurologists, cardiologists and psychologists. In Belgium, French- and Dutch- language hospitals are working in close collaboration to follow these pregnant patients. The national results are summarized in this paper.

• Authors: M Mhallem Gziri, F Goffin, F Debieve, F Amant
• Journal: Revue medicale de Liege (Rev Med Liege) Vol. 68 Issue 10 Pg. 527-30 (Oct 2013) ISSN: 0370-629X [Print] Belgium
• Vernacular Title: Cancer pendant la grossesse: importance d'un registre national et Européen.
• PMID: 24298727 (Publication Type: English Abstract, Journal Article)

Chemical References

• Antineoplastic Agents

Topics

• Adult
• Antineoplastic Agents (administration & dosage, therapeutic use)
• Belgium
• Cooperative Behavior
• Europe
• Female
• Follow-Up Studies
• Humans
• Incidence
• Infant, Newborn
• Middle Aged
• Pregnancy
• Pregnancy Complications, Neoplastic (epidemiology, pathology, therapy)
• Registries
• Young Adult